Prevalence and clinical characteristics of diabetic peripheral neuropathy in hospital patients with Type2 diabetes in Korea

Diabetic Medicine

Volumn 29, Issue 9, 2012, Pages

  Won, J C ^a   Kwon, H S ^b   Kim, C H ^c   Lee, J H ^b   Park, T S ^d   Ko, K S ^a   Cha, B Y ^b  

^a Inje University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Sejong General Hospital   (South Korea)

^d Chonbuk National University Medical School   (South Korea)

Author keywords

Diabetes; Neuropathy; Prevalence

Indexed keywords

ANTICONVULSIVE AGENT; GAMMA LINOLENIC ACID; HEMOGLOBIN A1C; INSULIN; OPIATE; ORAL ANTIDIABETIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; THIOCTIC ACID; TRICYCLIC ANTIDEPRESSANT AGENT;

ACHILLES REFLEX; ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC FOOT; DIABETIC HYPERTENSION; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD; MULTICENTER STUDY; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISEASE MANAGEMENT; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL NERVOUS SYSTEM DISEASES; PREVALENCE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84865131827     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03697.x     Document Type: Article

References (29)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
2. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH et al. Epidemic obesity and type2 diabetes in Asia. Lancet 2006; 368: 1681-1688.
3. Service KDA-HiRaA. Report of Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus: Diabetes in Korea 2007. 1st edition. Seoul: Goldfishery, 2008.
4. Argoff CE, Cole BE, Fishbain DA, Irving GA. Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc 2006; 81: S3-S11.
5. Boulton AJ. Whither clinical research in diabetic sensorimotor peripheral neuropathy? Problems of end point selection for clinical trials Diabetes Care 2007; 30: 2752-2753.
6. Hall GC, Carroll D, Parry D, McQuay HJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 2006; 122: 156-162.
7. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33: 2285-2293.
8. IDF. Diabetes Atlas 2006. Brussels: International Diabetes Federation, 2006.
9. Tapp RJ, Shaw JE, de Courten MP, Dunstan DW, Welborn TA, Zimmet PZ. Foot complications in Type2 diabetes: an Australian population-based study. Diabet Med 2003; 20: 105-113.
10. Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M et al. Prevalence of lower-extremity disease in the US adult population ≥40years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care 2004; 27: 1591-1597.
11. Lu B, Yang Z, Wang M, Gong W, Yang Y, Wen J et al. High prevalence of diabetic neuropathy in population-based patients diagnosed with type2 diabetes in the Shanghai downtown. Diabetes Res Clin Pract 2010; 88: 289-294.
12. Kamei N, Yamane K, Nakanishi S, Yamashita Y, Tamura T, Ohshita K et al. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening. J Diabetes Complications 2005; 19: 47-53.
13. Cheng WY, Jiang YD, Chuang LM, Huang CN, Heng LT, Wu HP et al. Quantitative sensory testing and risk factors of diabetic sensory neuropathy. J Neurol 1999; 246: 394-398.
14. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994; 17: 1281-1289.
15. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010; 33: S11-S61.
16. Chuang LM, Tsai ST, Huang BY, Tai TY. The status of diabetes control in Asia-a cross-sectional survey of 24317 patients with diabetes mellitus in 1998. Diabet Med 2002; 19: 978-985.
17. Barbosa AP, Medina JL, Ramos EP, Barros HP. Prevalence and risk factors of clinical diabetic polyneuropathy in a Portuguese primary health care population. Diabetes Metab 2001; 27: 496-502.
18. Boulton AJ. Guidelines for diagnosis and outpatient management of diabetic peripheral neuropathy. European Association for the Study of Diabetes, Neurodiab. Diabetes Metab 1998; 24: S55-S65.
19. Harris M, Eastman R, Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the US population. Diabetes Care 1993; 16: 1446-1452.
20. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 2008; 31: 464-469.
21. Lehto S, Ronnemaa T, Pyorala K, Laakso M. Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care 1996; 19: 607-612.
22. Pop-Busui R, Sima A, Stevens M. Diabetic neuropathy and oxidative stress. Diabetes Metab Res Rev 2006; 22: 257-273.
23. el-Shazly M, Abdel-Fattah M, Scorpiglione N, Benedetti MM, Capani F, Carinci F et al. Risk factors for lower limb complications in diabetic patients. The Italian Study Group for the Implementation of the St Vincent Declaration. J Diabetes Complications 1998; 12: 10-17.
24. Franklin GM, Shetterly SM, Cohen JA, Baxter J, Hamman RF. Risk factors for distal symmetric neuropathy in NIDDM. The San Luis Valley Diabetes Study. Diabetes Care 1994; 17: 1172-1177.
25. Ko SH, Kwon HS, Yu JM, Baik SH, Park IB, Lee JH et al. Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy. Diabet Med 2010; 27: 1033-1040.
26. Hahm JR, Kim BJ, Kim KW. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients. J Diabetes Complications 2004; 18: 79-85.
27. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004; 21: 114-121.
28. Tesfaye S. Advances in the management of diabetic peripheral neuropathy. Curr Opin Support Palliat Care 2009; 3: 136-143.
29. Malone JM, Snyder M, Anderson G, Bernhard VM, Holloway GA Jr, Bunt TJ. Prevention of amputation by diabetic education. Am J Surg 1989; 158: 520-523;discussion 523-524.